Blog

October 12, 2016

Provocative Thoughts Emerging From a Study of Psychotherapies for Panic Disorder

Author Picture

Barbara Milrod, MD

Weill Cornell Medical College, New York, New York

​​

Psychotherapies for Panic Disorder: A Tale of Two Sites was an exciting, landmark study that my colleagues (Dianne L. Chambless, PhD; Jacques P. Barber, PhD; and others) and I conducted, and several of its important points deserve highlighting. It’s an important achievement that this rigorously conducted study demonstrated that a time-limited, panic-focused psychodynamic psychotherapy (PFPP) had efficacy for patients who had panic disorder with and without agoraphobia. While smaller studies have shown the efficacy of PFPP, this is the first larger-scale, multisite study to do so. The evidence-based psychotherapy most often provided for anxiety disorders these days is cognitive-behavioral therapy (CBT). CBT is a powerful, effective treatment for panic disorder, and it performed well in this study, too. Nonetheless, this approach doesn’t benefit all patients, so having a variety of types of psychotherapy with different strategies and focuses is important to help patients in need.

Unfortunately, in our study, outcome analyses revealed site-by-treatment interactions. No investigators would wish to find site-by-treatment differences in outcome in a randomized controlled trial, and we are no exception. Patients in PFPP improved more at Cornell than those at University of Pennsylvania, whereas patients receiving applied relaxation training fared better at Penn than at Cornell. While the populations differed from one another in a number of crucial ways, these differences did not fully explain the site-by-treatment differences we observed. Like all unexpected research findings, this unexplained difference has led the investigators to explore more carefully which specific elements of the psychotherapies yielded greater improvements among which specific patients. Without scooping my co-investigators in the analyses they are conducting, I can say that we are currently using this wonderful dataset to analyze the following questions:

  1. Did specific moderators (pre-existing characteristics that patients have, like their age, for example) affect outcome within and across psychotherapies?
  2. Can specific (a priori) mediators of change be pinpointed as leading to improvement?
  3. How did responders to the different psychotherapies fare at 12-month follow-up?
  4. What, if anything, differed about the manualized, mostly adherent psychodynamic therapy that the therapists delivered to the patients at the 2 sites? (This question is in some ways the one most interesting to me, as a dynamic therapist.)

We expect that some of the answers to these questions will help the field of psychotherapy for anxiety to move forward with better understanding as to which treatments work better for which patients, how they work (which may or may not be related to underlying causes of illness), and how to improve the psychotherapy we offer to patients.

Financial disclosure:Dr Milrod has received a Cornell Clinical and Translational Science Center grant; receives support from the New York Community Trust in a fund established by DeWitt Wallace; has received honoraria for various academic talks; and has received book royalties from Taylor & Francis.​

Category: Anxiety
Link to this post: https://www.psychiatrist.com/blog/provocative-thoughts-emerging-from-a-study-of-psychotherapies-for-panic-disorder/
Related to Provocative Thoughts Emerging From a Study of Psychotherapies for Panic Disorder

2 thoughts on “Provocative Thoughts Emerging From a Study of Psychotherapies for Panic Disorder

  1. Would it be worth examining the personality attributes, ability to empathise etc and the psychological therapies “culture” of the two institutions?
  2. Unfortunately, these are variables that are difficult to operationalize and thus difficult to test. Therapists were mostly adherent to the psychotherapy protocols, but numbers of therapists involved in the study made it unlikely that we would find “therapist effects” (and we did not). The two sites were organized differently in terms of how patients met with the assessors, among other matters, but it is difficult to assess whether these differences had any bearing on outcome. Thank you for taking the time to read our paper!

    Best
    Barbara Milrod, M.D.

Leave a Reply

Archive

Browse By Author

Categories

Archive

Browse By Author

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...